Adina Rachel Kern-Goldberger, Sindhu Srinivas, Michael Harhay, Lisa D Levine
{"title":"External Validation of the Clinical Obstetric Co-Morbidity Index Across a Diverse Health System.","authors":"Adina Rachel Kern-Goldberger, Sindhu Srinivas, Michael Harhay, Lisa D Levine","doi":"10.1055/a-2572-1727","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The clinically-modified obstetric co-morbidity index (OB-CMI) is a co-morbidity-based scoring system that has been validated to predict severe maternal morbidity (SMM) in a single tertiary, academic hospital using an internal SMM definition. We aimed to validate the OB-CMI for prediction of SMM as defined by the CDC during delivery admissions across a diverse health system.</p><p><strong>Study design: </strong>This is a retrospective cohort study evaluating all deliveries in a large health system encompassing academic and community hospitals. Data from 2019-2021 were extracted from the electronic health record (EHR) and validated with chart review. An OB-CMI score was calculated for each patient using established diagnosis codes and EHR data. The primary outcome was non-transfusion SMM (defined by the CDC) during the delivery admission. Patient characteristics were evaluated by hospital, and hospital-specific receiver-operator characteristic (ROC) curves were constructed and compared.</p><p><strong>Results: </strong>42,130 deliveries were included with significant differences in all demographic, clinical, and obstetric characteristics across the hospitals including age, BMI, race/ethnicity, insurance type, preterm birth and preeclampsia rates. (Table). Median OB-CMI score and rate of elevated OB-CMI score (≥ 6) were also significantly different. ROC curves for OB-CMI and SMM for each hospital are noted in the Figure with an area-under-the curve (AUC) range from 0.77 - 0.83, and no significant differences across hospitals (p = 0.32).</p><p><strong>Conclusion: </strong>In a large cohort of patients delivering across a diverse hospital system, the clinical OB-CMI score similarly predicted SMM despite differences in demographic and clinical characteristics among the hospitals. This validation of the OB-CMI supports the use of this scoring system in variegated clinical settings, which can inform widescale uptake and clinical integration of OB-CMI scoring to improve obstetric risk stratification.</p>","PeriodicalId":7584,"journal":{"name":"American journal of perinatology","volume":" ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of perinatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2572-1727","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The clinically-modified obstetric co-morbidity index (OB-CMI) is a co-morbidity-based scoring system that has been validated to predict severe maternal morbidity (SMM) in a single tertiary, academic hospital using an internal SMM definition. We aimed to validate the OB-CMI for prediction of SMM as defined by the CDC during delivery admissions across a diverse health system.
Study design: This is a retrospective cohort study evaluating all deliveries in a large health system encompassing academic and community hospitals. Data from 2019-2021 were extracted from the electronic health record (EHR) and validated with chart review. An OB-CMI score was calculated for each patient using established diagnosis codes and EHR data. The primary outcome was non-transfusion SMM (defined by the CDC) during the delivery admission. Patient characteristics were evaluated by hospital, and hospital-specific receiver-operator characteristic (ROC) curves were constructed and compared.
Results: 42,130 deliveries were included with significant differences in all demographic, clinical, and obstetric characteristics across the hospitals including age, BMI, race/ethnicity, insurance type, preterm birth and preeclampsia rates. (Table). Median OB-CMI score and rate of elevated OB-CMI score (≥ 6) were also significantly different. ROC curves for OB-CMI and SMM for each hospital are noted in the Figure with an area-under-the curve (AUC) range from 0.77 - 0.83, and no significant differences across hospitals (p = 0.32).
Conclusion: In a large cohort of patients delivering across a diverse hospital system, the clinical OB-CMI score similarly predicted SMM despite differences in demographic and clinical characteristics among the hospitals. This validation of the OB-CMI supports the use of this scoring system in variegated clinical settings, which can inform widescale uptake and clinical integration of OB-CMI scoring to improve obstetric risk stratification.
期刊介绍:
The American Journal of Perinatology is an international, peer-reviewed, and indexed journal publishing 14 issues a year dealing with original research and topical reviews. It is the definitive forum for specialists in obstetrics, neonatology, perinatology, and maternal/fetal medicine, with emphasis on bridging the different fields.
The focus is primarily on clinical and translational research, clinical and technical advances in diagnosis, monitoring, and treatment as well as evidence-based reviews. Topics of interest include epidemiology, diagnosis, prevention, and management of maternal, fetal, and neonatal diseases. Manuscripts on new technology, NICU set-ups, and nursing topics are published to provide a broad survey of important issues in this field.
All articles undergo rigorous peer review, with web-based submission, expedited turn-around, and availability of electronic publication.
The American Journal of Perinatology is accompanied by AJP Reports - an Open Access journal for case reports in neonatology and maternal/fetal medicine.